Особенности повреждения миокарда при COVID-19

Автор: Хамидов С.Х., Обрезан А.Г., Лобанова П.С., Азаренко С.В.

Журнал: Евразийский кардиологический журнал @eurasian-cardiology-journal

Статья в выпуске: 3, 2022 года.

Бесплатный доступ

Данная работа посвящена литературному обзору опубликованных статей, в которых исследования сфокусированы на изучении частоты развития, структуры осложнений сердечно-сосудистых заболеваний у пациентов с COVID-19, возникших прижизненно и посмертно: миокардита, миокардиального повреждения, ОИМ, других тромботических событий. В некоторых исследованиях также приведены сравнительные данные COVID-19+ и COVID-19-пациентов, структура осложнений и доля смертности. Результаты изученных материалов свидетельствуют о том, что частота развития кардиологических осложнений и число летальных исходов достоверно чаще встречаются у пациентов с сопутствующими заболеваниями как: артериальная гипертензия, сахарный диабет, ожирение, ХБП, нарушение ритма. Пациенты старше 60 лет находятся в группе повышенного риска тяжёлого течения заболевания, это объясняется тем, что у этих лиц имеются сопутствующие хронические заболевания, которые из-за острого инфекционного процесса декомпенсируются, снижая адаптационные возможности организма, приводят к ухудшению показателей выживаемости.

Еще

Covid-19, миокардит, миокардиальное повреждение, острый инфаркт миокарда

Короткий адрес: https://sciup.org/143179490

IDR: 143179490 | DOI: 10.38109/2225-1685-2022-3-66-72

Список литературы Особенности повреждения миокарда при COVID-19

Bavishi C., Bonow R. O., Trivedi V., Abbott J. D., Messerli F. H., Bhatt D. L. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis. 2020; 63 (5): 682-689. https://doi.org/10.1016/j.pcad.2020.05.013
Halushka M. K., Vander Heide R. S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021; 50: 107300. PMID:33132119.https://doi.org/10.1016/j.carpath.2020.107300
Благова О. В. Оценка уровня антикардиальных антител у больных с тяжелым и среднетяжелым течением COVID-19 (корреляции с клинической картиной и прогнозом) / О. В. Благова [и др.] // Российский кардиологический журнал. - 2020. - 25 (11): 4054.. [Blagova O. V., Varionchik N. V., Zaydenov V. A., Savina P. O., Sarkisova N. D. Anticardiac antibodies in patients with severe and moderate COVID-19 (correlations with the clinical performance and prognosis). Russian Federationn Journal of Cardiology. 2020; 25 (11): 4054. (In Russ.)]. https://doi.org/10.15829/29/1560-4071-2020-4054
Chung, Mina K. et al. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circulation research vol. 128, 8 (2021): 1214-1236. https://doi.org/10.1161/CIRCRESAHA.121.317997
The CAPACITY-COVID Collaborative Consortium and LEOSS Study Group, Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries, European Heart Journal, 2021; ehab656. https://doi.org/10.1093/eurheartj/ehab656
Linschoten M., Peters S., van Smeden M., et al. Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care. 2020; 9 (8): 817-823. PMID:33222494.https://doi.org/10.1177/2048872620974605
Сережина Е. К. Патофизиологические механизмы и нозологические формы сердечно-сосудистой патологии при COVID-19 / Е. К. Сережина, А. Г. Обрезан // Кардиология. - 2020. - 60 (8): 23-26. [Serezhina E. K., Obrezan A. G. Cardiovascular Pathology in Patients With COVID-19. Kardiologiia. 2020; 60 (8): 23-26. (In Russ.)]. https://doi.org/10.18087/cardio.2020.8.n1215
Pinto D. S. (2021). COVID-19: Myocardial infarction and other coronary artery disease issues. UpToDate. Retrieved April, 2022, from https://www.uptodate.com/contents/covid-19-myocardial-infarction-and-other-coronary-artery-disease-issues#H2554956222
Thygesen K., Alpert J. S., Jaffe A. S., et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018; 72 (18): 2231-2264. https://doi.org/10.1016/j.jacc.2018.08.1038
James L. Januzzi Jr., MD, FACC. Troponin and BNP Use in COVID-19. Mar 18, 2020 Cardiology Magazine. https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnp-use-in-covid19
Abate S. M., Mantefardo B., Nega S., Chekole Y. A., Basu B., Ali S. A., Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond). 2021 Aug; 68: 102594. PMID:34336202.https://doi.org/10.1016/j.amsu.2021.102594
Bonow R. O., Fonarow G. C., O’Gara P. T., Yancy C. W. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 2020; 5 (7): 751-753. https://doi.org/10.1001/jamacardio.2020.1105
Giustino G., Croft L. B., Stefanini G. G., et al. Characterization of Myocardial Injury in Patients With COVID-19. J Am Coll Cardiol. 2020; 76 (18): 2043-2055. PMID:33121710.https://doi.org/10.1016/j.jacc.2020.08.069
De Michieli L., Ola O., Knott J. D., et al. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19. Clinical Chemistry. 2021 Aug; 67 (8): 1080-1089. PMID:33860295.https://doi.org/10.1093/clinchem/hvab062
Poterucha T. J., Elias P., Jain S. S., et al. Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19. J Am Heart Assoc. 2021; 10 (1): e018476. https://doi.org/10.1161/JAHA.120.018476
Bardají A., Carrasquer A., Sánchez-Giménez R., et al. Prognostic implications of myocardial injury in patients with and without COVID-19 infection treated in a university hospital. Rev Esp Cardiol (Engl Ed). 2021; 74 (1): 24-32. PMID:33144126.https://doi.org/10.1016/j.recesp.2020.08.009
Metkus T. S., Sokoll L. J., Barth A. S., et al. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome. Circulation. 2021; 143 (6): 553-565. https://doi.org/10.1161/CIRCULATIONAHA.120.050543
Терещенко С. Н. Диагностика и лечение миокардитов / С. Н. Терещенко [и др.] // Евразийский Кардиологический Журнал. - 2019. - (3): 4-33. [Tereshchenko S. N., Zhirov I. V., Masenko V. P., Narusov O. Yu., Nasonova S. N., Samko A. N., Stukalova O. V., Shariya M. A. DIAGNOSIS AND TREATMENT OF MYOCARDITIDES. Eurasian heart journal. 2019; (3): 4-33. (In Russ.).] https://doi.org/10.38109/2225-1685-2019-3-4-33
Boehmer T. K., Kompaniyets L., Lavery A. M., et al. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021; 70 (35): 1228-1232. Published 2021 Sep 3. https://doi.org/10.15585/mmwr.mm7035e5
Siripanthong B., Nazarian S., Muser D., et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020; 17 (9): 1463-1471. PMID:32387246.https://doi.org/10.1016/j.hrthm.2020.05.001
Kociol R. D., Cooper L. T., Fang J. C., et al. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association. Circulation. 2020; 141 (6): e69-e92. https://doi.org/10.1161/CIR.0000000000000745
Inciardi R. M., Lupi L., Zaccone G., et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (7): 819-824. PMID:32219357.URL: https://pubmed.ncbi.nlm.nih.gov/32219357
In-Cheol Kim, Jin Young Kim, Hyun Ah Kim, Seongwook Han, COVID-19-related myocarditis in a 21-year-old female patient, European Heart Journal, Volume 41, Issue 19, 14 May 2020, Page 1859, https://doi.org/10.1001/jamacardio.2020.1096
Ammirati E., Lupi L., Palazzini M., et al. Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis. Circulation. 2022; 145 (15): 1123-1139. PMID:35404682.https://doi.org/10.1161/CIRCULATIONAHA.121.056817
Eiros R., Barreiro-Pérez M., Martín-García A., et al. Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers [published online ahead of print, 2021 Nov 5]. Rev Esp Cardiol (Engl Ed). 2021; S1885-5857(21)00324-8. PMID:34866030.https://doi.org/10.1016/j.rec.2021.11.001
Rajpal S., Tong M. S., Borchers J., et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2021; 6 (1): 116-118. https://doi.org/10.1001/jamacardio.2020.4916
Starekova J., Bluemke D. A., Bradham W. S., et al. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021; 6 (8): 945-950. https://doi.org/10.1001/jamacardio.2020.7444
Diaz G. A., Parsons G. T., Gering S. K., Meier A. R., Hutchinson I. V., Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA. 2021; 326 (12): 1210-1212. https://doi.org/10.1001/jama.2021.13443
Montgomery J., Ryan M., Engler R., et al. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021; 6 (10): 1202-1206. https://doi.org/10.1001/jamacardio.2021.2833
Witberg G., Barda N., Hoss S., et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med. 2021; 385 (23): 2132-2139. https://doi.org/10.1056/NEJMoa2110737
Solomon M. D., McNulty E. J., Rana J. S., et al. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. 2020; 383 (7): 691-693. https://doi.org/10.1056/NEJMc2015630
Smilowitz N. R., Subashchandran V., Yuriditsky E., Horowitz J. M., Reynolds H. R., Hochman J. S., Berger J. S. Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19. Am Heart J. 2021 Jan; 231: 93-95. PMID:33181067.https://doi.org/10.1016/j.ahj.2020.10.075
Rashid M., Wu J., Timmis A., et al. Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. J Intern Med. 2021; 290 (1): 88-100. https://doi.org/10.1111/joim.13246
Rodriguez-Leor O., Cid Alvarez A. B., Pérez de Prado A., et al. Inhospital outcomes of COVID-19 ST-elevation myocardial infarction patients. EuroIntervention. 2021; 16 (17): 1426-1433. https://doi.org/10.4244/EIJ-D-20-00935
Saad M., Kennedy K. F., Imran H., et al. Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. JAMA. 2021; 326 (19): 1940-1952. https://doi.org/10.1001/jama.2021.18890
Abate S. M., Mantefardo B., Nega S., Chekole Y. A., Basu B., Ali S. A., Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond). 2021 Aug; 68: 102594. https://doi.org/10.1016/j.amsu.2021.102594
Manolis A. S., Manolis A. A., Manolis T. A., Melita H. COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges. Journal of Cardiovascular Pharmacology and Therapeutics. September 2021: 399-414. https://doi.org/10.1177%2F10742484211011026
Kogan E, Berezovskiy Y., Blagova O., Kukleva A., Semyonova L., Gretsov E., Ergeshov A. Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19. Diagn Pathol. 2022 Feb 17; 17 (1): 31. PMID:35177093.https://doi.org/10.1186/s13000-022-01207-6
Wallace M., Oliver S. COVID-19 mRNA vaccines in adolescents and young adults: benefit-risk discussion. Presented at the Advisory Committee on Immunization Practices Meeting, Atlanta, June 23-25, 2021 (https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/05-COVID-Wallace-508.pdf opens in new tab).
Primessnig, U., Pieske, B. M., and Sherif, M. (2021) Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic. ESC Heart Failure, 8: 333-343. https://doi.org/10.1002/ehf2.13075
Watanabe Y., Miyachi H., Mozawa K., et al. Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo. Intern Med. 2021; 60 (23): 3693-3700. https://doi.org/10.2169/internalmedicine.8220-21
Paul Jie Wen Tern, Yilin Jiang, Yee How Lau, Wael Almahmeed, S. Gunavathy Selvaraj, Jack Wei Chieh Tan, Wan Azman Wan Ahmad, Jonathan Yap, Khung Keong Yeo, MBBS. Impact of COVID-19 on Acute MI and Percutaneous Coronary Intervention Rates and Outcomes in South East Asia and the Middle East. Journal of Asian Pacific Society of Cardiology 2022; 1: e05. https://doi.org/10.15420/japsc.2021.12
Jabagi M. J., Botton J., Bertrand M., et al. Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA. 2022; 327 (1): 80-82. https://doi.org/10.1001/jama.2021.21699
Y. N. Aye, A. S. Mai, A. Zhang, O. Z. H. Lim, N. Lin, C. H. Ng, M. Y. Chan, J. Yip, P.-H. Loh, N. W. S. Chew, Acute myocardial infarction and myocarditis following COVID-19 vaccination, QJM: An International Journal of Medicine, 2021; hcab252, https://doi.org/10.1093/qjmed/hcab252

Еще

Статья обзорная